How many clinical trials are studying Leuprolide Acetate?

4 recruiting trials in our tracked data involve Leuprolide Acetate.

What conditions is Leuprolide Acetate being studied for?

In our tracked recruiting trials, Leuprolide Acetate is being studied in trials for Prostate Cancer, Stage IVB Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8.

Leuprolide Acetate: clinical trials recruiting now

Q: Is Leuprolide Acetate FDA-approved?

Yes. According to the FDA drug label available through openFDA, Leuprolide Acetate is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA drug label

FDA-approved: Yes. Leuprolide Acetate appears in the FDA drug-label database. Marketed as Vabrinty.

FDA-approved use

VABRINTY is indicated for the treatment of advanced prostate cancer. VABRINTY is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of advanced prostate cancer. ( 1 )

FDA label via openFDA

Phase breakdown

Phase 2 2 Phase 3 2

Conditions being studied

Condition	Trials
Prostate Cancer · Leuprolide Acetate for Prostate Cancer	4
Stage IVB Prostate Cancer AJCC v8 · Leuprolide Acetate for Stage IVB Prostate Cancer AJCC v8	3
Stage IV Prostate Cancer AJCC v8	2
Stage IVA Prostate Cancer AJCC v8	2
Biochemically Recurrent Prostate Carcinoma	1
Castration Levels of Testosterone	1
Castration-Sensitive Prostate Carcinoma	1
High-risk Prostate Cancer	1
Metastatic Prostate Adenocarcinoma	1
Metastatic Prostate Carcinoma	1
Metastatic Prostatic Adenocarcinoma	1
Prostate Adenocarcinoma	1

Recruiting trials involving Leuprolide Acetate

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
NCT03541928 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT03678025 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 338 locations
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
NCT04734730 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations

Common questions

Is Leuprolide Acetate FDA-approved?

Yes, marketed as Vabrinty.

How many recruiting trials involve Leuprolide Acetate?

4 recruiting trials across 12 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.